These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Resistance to the combination of beta-lactams and beta-lactamase inhibitors]. Alós JI, Oteo J. Rev Esp Quimioter; 1999 Sep; 12(3):205-10. PubMed ID: 10878509 [No Abstract] [Full Text] [Related]
29. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis. Dinçer I, Ergin A, Kocagöz T. Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094 [Abstract] [Full Text] [Related]
31. [ESBL's: increase is alarming, but no reason to panic]. Haneveld JK. Tijdschr Diergeneeskd; 2010 Jun 15; 135(12):498-9. PubMed ID: 20608448 [No Abstract] [Full Text] [Related]
32. [Beta-lactamase inhibitors. A progress indeed, but their combination with beta lactams is not a panacea]. Denis F, Mounier M, Philippon A. Rev Prat; 1994 Jan 15; 44(2):215-9. PubMed ID: 8178078 [No Abstract] [Full Text] [Related]
33. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Brauers J, Frank U, Kresken M, Rodloff AC, Seifert H. Clin Microbiol Infect; 2005 Jan 15; 11(1):24-30. PubMed ID: 15649300 [Abstract] [Full Text] [Related]
36. An animal farm called extended-spectrum beta-lactamase: antimicrobial resistance as a zoonosis. Pappas G. Clin Microbiol Infect; 2011 Jun 15; 17(6):797-8. PubMed ID: 21463398 [No Abstract] [Full Text] [Related]